Volume 7, Number 6—December 2001
Dispatch
Legionella-Like and Other Amoebal Pathogens as Agents of Community-Acquired Pneumonia
Thomas J. Marrie*
, Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study Group
, Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study Group
Table 2
Summary of selected characteristics of four patients infected with Legionella-like amoebal pathogen (LLAP)-4
| No. | Age | Sex | Temp | Symptoms | LOS | WBC | Antibiotics | Comments | Antibody titer | Co-pathogens |
|---|---|---|---|---|---|---|---|---|---|---|
| TM37 | 93 | M | 38.3 | nausea, myalgia, shortness of breath, nonproductive cough, chest pain | 8 | 18.2 | erythromycin; cefuroxime | admitted from a nursing home, sustained a non q wave myocardial infarction | IgG 1:400 and 1:400 | None |
| TM11 | 87 | F | 39.0 | nonproductive cough, chills | 11 | 8.7 | erythromycin; cefuroxime | IgG 0 and 1:100 | None | |
| ML13 | 54 | M | 38.4 | abdominal pain, nonproductive cough, myalgia, chest pain | 17 | 2.2 | erythromycin; ceftazidime, ribavirin | bone marrow transplant; required intensive care unit treatment | IgM 25 and 0; IgG 200 and 1:400 | RSV |
| LN 9 |
63 |
M |
36.8 |
shortness of breath, chills |
10 |
20.8 |
erythromycin, cefuroxime |
IgM 1:200 and 1:200 |
Strepto-coccus pneumoniae |
|
M = male; F = female; LOS = length of stay in days; wbc = leukocyte count; antibody titer = first value is from acute-phase sample and second from convalescent-phase sample.
1R. Duperval, S. Field, T. Louie, S. Houston, M. Gribble, K. Williams, L. Nicolle, R. Grossman, I. Salit, R. Saginur, D. Gregson, M. Laverdiere, Jean Joly, T. Marrie, and J. Hutchinson.
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.